Order Article Reprints

Nelli F, Signorelli C, Fabbri A, Giannarelli D, Virtuoso A, Giron Berrios JR, Marrucci E, Fiore C, Schirripa M, Chilelli MG, et al. Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study. Cancers. 2023; 15(14):3625. https://doi.org/10.3390/cancers15143625

Nelli, Fabrizio, Carlo Signorelli, Agnese Fabbri, Diana Giannarelli, Antonella Virtuoso, Julio Rodrigo Giron Berrios, Eleonora Marrucci, Cristina Fiore, Marta Schirripa, Mario Giovanni Chilelli, and et al. 2023. "Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study" Cancers 15, no. 14: 3625. https://doi.org/10.3390/cancers15143625

Nelli, F., Signorelli, C., Fabbri, A., Giannarelli, D., Virtuoso, A., Giron Berrios, J. R., Marrucci, E., Fiore, C., Schirripa, M., Chilelli, M. G., Primi, F., Panichi, V., Topini, G., Silvestri, M. A., & Ruggeri, E. M. (2023). Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study. Cancers, 15(14), 3625. https://doi.org/10.3390/cancers15143625